Germline BRCA1/2 mutations are found in approximately 18% of high grade serous ovarian cancer (HGSOC) patients [4,5], while exclusive somatic mutations in BRCA1/2 occur in about 3–8% [6,7]. The gene discussed is BRCA1; the disease is ovarian serous adenocarcinoma.